| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.74 | 0.03 |